Managing Oral Oncolytics through COVID-19

Due to the COVID-19 pandemic restrictions have been placed on hospitals and clinics alike. With telehealth and the availability of many oral oncolytics patients being treated for cancer have been given an opportunity to not halt therapy due to these restrictions. During Managing Oral Oncolytics through COVID-19, a Pharmacy Times Webinar we provide an overview of how the COVID-19 pandemic has impacted the treatment and management of patients with cancer. We review newly approved oral oncolytics, as well as the challenges and benefits of prescribing and transitioning to oral oncolytics from IV medications.